Orodispersible Tablets Market
According to Intent Market Research, the Orodispersible Tablets Market is expected to grow from USD 1,068.3 million in 2024-e at a CAGR of 11.9% to touch USD 2,102.6 million by 2030. The Orodispersible Tablets Market is dominated by key players such as, Amgen Inc., Hikma Pharmaceuticals, Johnson & Johnson Services, Inc., Glenmark Pharmaceuticals, and Mylan Pharmaceuticals.